246 related articles for article (PubMed ID: 15516392)
21. Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage.
Saito K; Haruki A; Ishikawa H; Takahashi T; Nagase H; Koyama M; Endo M; Hirahara F
J Obstet Gynaecol Res; 2007 Jun; 33(3):254-8. PubMed ID: 17578351
[TBL] [Abstract][Full Text] [Related]
22. Predictors of cesarean section following elective post-dates induction of labor in nullipara with uncomplicated singleton vertex pregnancies.
Edris FE; von Dadelszen P; Ainsworth LM; Liston RM
Saudi Med J; 2006 Aug; 27(8):1167-72. PubMed ID: 16883446
[TBL] [Abstract][Full Text] [Related]
23. Carbetocin at elective caesarean section: a sequential allocation trial to determine the minimum effective dose in obese women.
Drew T; Balki M; Farine D; Ye XY; Downey K; Carvalho JCA
Anaesthesia; 2020 Mar; 75(3):331-337. PubMed ID: 31867715
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage.
Jackson KW; Allbert JR; Schemmer GK; Elliot M; Humphrey A; Taylor J
Am J Obstet Gynecol; 2001 Oct; 185(4):873-7. PubMed ID: 11641669
[TBL] [Abstract][Full Text] [Related]
25. Oxytocin infusion in laparoscopic myomectomy may decrease operative blood loss.
Wang CJ; Lee CL; Yuen LT; Kay N; Han CM; Soong YK
J Minim Invasive Gynecol; 2007; 14(2):184-8. PubMed ID: 17368254
[TBL] [Abstract][Full Text] [Related]
26. Risk of uterine rupture and adverse perinatal outcome at term after cesarean delivery.
Spong CY; Landon MB; Gilbert S; Rouse DJ; Leveno KJ; Varner MW; Moawad AH; Simhan HN; Harper M; Wapner RJ; Sorokin Y; Miodovnik M; Carpenter M; Peaceman AM; O'Sullivan MJ; Sibai BM; Langer O; Thorp JM; Ramin SM; Mercer BM;
Obstet Gynecol; 2007 Oct; 110(4):801-7. PubMed ID: 17906012
[TBL] [Abstract][Full Text] [Related]
27. Cesarean section on request at 39 weeks: impact on shoulder dystocia, fetal trauma, neonatal encephalopathy, and intrauterine fetal demise.
Hankins GD; Clark SM; Munn MB
Semin Perinatol; 2006 Oct; 30(5):276-87. PubMed ID: 17011400
[TBL] [Abstract][Full Text] [Related]
28. [Intervals for increasing the dosage of oxytocin].
Adelwöhrer NE; Rollett H; Haas J; Auner J
Zentralbl Gynakol; 1993; 115(9):396-9. PubMed ID: 8237158
[TBL] [Abstract][Full Text] [Related]
29. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
[TBL] [Abstract][Full Text] [Related]
30. Intravenous oxytocin in patients undergoing elective cesarean section.
Zarzur E
Anesth Analg; 1998 Jun; 86(6):1334. PubMed ID: 9620531
[No Abstract] [Full Text] [Related]
31. Use of oxytocin to prevent haemorrhage at caesarean section--a survey of practice in the United Kingdom.
Wedisinghe L; Macleod M; Murphy DJ
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):27-30. PubMed ID: 17544563
[TBL] [Abstract][Full Text] [Related]
32. The Median Effective Dose of Oxytocin Needed to Prevent Uterine Atony During Cesarean Delivery in Elderly Parturients.
Wei CN; Deng JL; Dong JH; Ping ZP; Chen XZ
Drug Des Devel Ther; 2020; 14():5451-5458. PubMed ID: 33335388
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the Mean Minimum Dose of Bolus Oxytocin for Proper Uterine Contraction during Cesarean Section.
Beiranvand S; Karimi A; Vahabi S; Amin-Bidokhti A
Curr Clin Pharmacol; 2019; 14(3):208-213. PubMed ID: 31124424
[TBL] [Abstract][Full Text] [Related]
34. Effect of uterotonics on intra-operative blood loss during laparoscopy-assisted vaginal hysterectomy: a randomised controlled trial.
Chang FW; Yu MH; Ku CH; Chen CH; Wu GJ; Liu JY
BJOG; 2006 Jan; 113(1):47-52. PubMed ID: 16398771
[TBL] [Abstract][Full Text] [Related]
35. Rupture of the scarred uterus.
Grossetti E; Vardon D; Creveuil C; Herlicoviez M; Dreyfus M
Acta Obstet Gynecol Scand; 2007; 86(5):572-8. PubMed ID: 17464586
[TBL] [Abstract][Full Text] [Related]
36. The effect of initiating intravenous oxytocin infusion before uterine incision on the blood loss during elective cesarean section: a randomized clinical trial.
Abdelaleem AA; Abbas AM; Thabet AL; Badran E; El-Nashar IH
J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3723-3728. PubMed ID: 29712515
[No Abstract] [Full Text] [Related]
37. Dose-response study of spinal hyperbaric ropivacaine for cesarean section.
Chen XZ; Chen H; Lou AF; Lü CC
J Zhejiang Univ Sci B; 2006 Dec; 7(12):992-7. PubMed ID: 17111469
[TBL] [Abstract][Full Text] [Related]
38. Oxytocin infusion rates for maintaining uterine tone during non-elective cesarean section in laboring patients: a randomized, controlled trial.
Mohta M; Siddiqui S; Chilkoti GT; Agarwal R
J Anesth; 2022 Aug; 36(4):456-463. PubMed ID: 35484429
[TBL] [Abstract][Full Text] [Related]
39. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section.
Thomas JS; Koh SH; Cooper GM
Br J Anaesth; 2007 Jan; 98(1):116-9. PubMed ID: 17142825
[TBL] [Abstract][Full Text] [Related]
40. The optimal oxytocin infusion rate for preventing uterine atony during cesarean delivery in elderly parturients with prior history of cesarean delivery.
Wang LY; Wang J; Dong JH; Ping ZP; Chen XZ; Wei CN
Front Pharmacol; 2023; 14():1211693. PubMed ID: 37576820
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]